ATE247169T1 - Bacteriophagen-lysine und deren anwendungen zum vernichten von und testen auf bakterien - Google Patents

Bacteriophagen-lysine und deren anwendungen zum vernichten von und testen auf bakterien

Info

Publication number
ATE247169T1
ATE247169T1 AT92303533T AT92303533T ATE247169T1 AT E247169 T1 ATE247169 T1 AT E247169T1 AT 92303533 T AT92303533 T AT 92303533T AT 92303533 T AT92303533 T AT 92303533T AT E247169 T1 ATE247169 T1 AT E247169T1
Authority
AT
Austria
Prior art keywords
bacteria
bacteriophagen
lysines
destroying
testing
Prior art date
Application number
AT92303533T
Other languages
English (en)
Inventor
Michael John Gasson
Original Assignee
Inst Of Food Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Of Food Res filed Critical Inst Of Food Res
Application granted granted Critical
Publication of ATE247169T1 publication Critical patent/ATE247169T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/783—Microorganisms; Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92303533T 1991-04-20 1992-04-21 Bacteriophagen-lysine und deren anwendungen zum vernichten von und testen auf bakterien ATE247169T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9108498A GB2255561B (en) 1991-04-20 1991-04-20 Lysins from bacteriophages

Publications (1)

Publication Number Publication Date
ATE247169T1 true ATE247169T1 (de) 2003-08-15

Family

ID=10693655

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92303533T ATE247169T1 (de) 1991-04-20 1992-04-21 Bacteriophagen-lysine und deren anwendungen zum vernichten von und testen auf bakterien

Country Status (7)

Country Link
US (2) US5763251A (de)
EP (2) EP0510907B1 (de)
AT (1) ATE247169T1 (de)
AU (1) AU650737B2 (de)
CA (1) CA2066387C (de)
DE (1) DE69233152T2 (de)
GB (1) GB2255561B (de)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10500012A (ja) * 1994-05-12 1998-01-06 クウエスト・インターナシヨナル・ベー・ベー 溶解素による乳酸バクテリアの培養物を溶解する方法および得られる溶解培養物の使用
WO1995031562A1 (en) * 1994-05-12 1995-11-23 Quest International B.V. Process for inhibiting the growth of a culture of lactic acid bacteria, and optionally lysing the bacterial cells, and uses of the resulting lysed culture
DE59510532D1 (de) * 1994-09-09 2003-02-20 Biotec Lab Ltd Aufschluss von bakterienzellen durch phagenlysine
US20030129146A1 (en) * 1997-10-31 2003-07-10 Vincent Fischetti The use of bacterial phage associated lysing proteins for treating bacterial dental caries
US7232576B2 (en) 1997-10-31 2007-06-19 New Horizons Diagnostics Corp Throat lozenge for the treatment of Streptococcus Group A
US6056954A (en) * 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US6399098B1 (en) 1997-10-31 2002-06-04 New Horizons Diagnostics Corp Composition for treating dental caries caused by streptococcus mutans
US6432444B1 (en) 1997-10-31 2002-08-13 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymes for treating dermatological infections
US6399097B1 (en) 1997-10-31 2002-06-04 New Horizons Diagnostics Corporation Composition for treatment of a bacterial infection of the digestive tract
US20030129147A1 (en) * 1997-10-31 2003-07-10 Vincent Fischetti Use of bacterial phage associated lysing proteins for treating bacterial dental caries
US6406692B1 (en) 1997-10-31 2002-06-18 New Horizons Diagnostics Corp Composition for treatment of an ocular bacterial infection
US6423299B1 (en) 1997-10-31 2002-07-23 Vincent Fischetti Composition for treatment of a bacterial infection of an upper respiratory tract
US6277399B1 (en) 1997-10-31 2001-08-21 New Horizon Diagnostics Corporation Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections
US20020136712A1 (en) * 1997-10-31 2002-09-26 Fischetti Vincent Bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of colonization and infections caused by streptococcus pneumoniae
US6428784B1 (en) * 1997-10-31 2002-08-06 New Horizons Diagnostics Corp Vaginal suppository for treating group B Streptococcus infection
US6752988B1 (en) * 2000-04-28 2004-06-22 New Horizons Diagnostic Corp Method of treating upper resiratory illnesses
US20030082110A1 (en) * 1997-10-31 2003-05-01 Vincent Fischetti Use of bacterial phage associated lysing proteins for treating bacterial dental caries
US6143551A (en) * 1997-12-29 2000-11-07 Schering Aktiengesellschaft Delivery of polypeptide-encoding plasmid DNA into the cytosol of macrophages by attenuated listeria suicide bacteria
US6391626B1 (en) 1999-08-23 2002-05-21 3M Innovative Properties Company Culture medium and device using ballasted pH indicators for detection and enumeration of microorganisms
US20020127215A1 (en) * 1999-09-14 2002-09-12 Lawrence Loomis Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
US7063837B2 (en) * 1999-09-14 2006-06-20 New Horizons Diagnostics Corp Syrup composition containing phage associated lytic enzymes
ATE313341T1 (de) 2000-01-11 2006-01-15 Intralytix Inc Polymermischungen als bioabbaubare matrizen zur herstellung von biokompositen
US6436661B1 (en) * 2000-04-13 2002-08-20 3M Innovative Properties Company Bacteria and bacteriophage detection using immobilized enzyme substrates
US20020187136A1 (en) * 2000-04-28 2002-12-12 Lawrence Loomis Use of bacterial phage associated lysing enzymes for treating various illnesses
US6395504B1 (en) 2000-09-01 2002-05-28 New Horizons Diagnostics Corp. Use of phage associated lytic enzymes for the rapid detection of bacterial contaminants
CA2427928A1 (en) * 2000-11-02 2002-12-27 New Horizons Diagnostics Corporation The use of bacterial phage associated lytic enzymes to prevent food poisoning
WO2003000010A2 (en) * 2001-06-20 2003-01-03 Mayo Foundation For Medical Education And Research Adenosyl-cobalamin fortified compositions
US20040213765A1 (en) * 2001-07-13 2004-10-28 Vincent Fischetti Use of bacterial phage associated lytic enzymes to prevent food poisoning
WO2003008564A2 (en) 2001-07-18 2003-01-30 Instytut Immunologii I Terapii Doswiadczalnej Pan Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections
MXPA04002899A (es) * 2001-09-27 2005-07-01 Gangen Inc Bacteriofagos deficientes en lisina, que tienen inmunogenicidad reducida.
AU2002368047A1 (en) * 2001-12-06 2004-02-09 The Rockefeller University A novel method to identify targets for antibiotic development
GB0202556D0 (en) * 2002-02-04 2002-03-20 Danisco Novel Protein
JP4490112B2 (ja) 2002-04-12 2010-06-23 コロラド・スクール・オブ・マインズ 標的細菌性細胞を感染させるためにファージを使用する低濃度の標的細菌を検出するための方法
US8216780B2 (en) 2002-04-12 2012-07-10 Microphage (Tm) Incorporated Method for enhanced sensitivity in bacteriophage-based diagnostic assays
AU2003240505A1 (en) * 2002-06-05 2003-12-22 Iowa State University Research Foundation, Inc. Bacteriophage and enzymes lytic to salmonellae
US20040081646A1 (en) * 2002-08-29 2004-04-29 Engler Jeffrey A. Group B Streptococcal phage lysin
US20050129711A1 (en) * 2002-11-14 2005-06-16 Janakiraman Ramachandran Incapacitated whole-cell immunogenic bacterial compositions produced by recombinant expression
WO2008157384A2 (en) 2007-06-15 2008-12-24 Microphage Incorporated Method of detection of microorganisms with enhanced bacteriophage amplification
WO2006105504A1 (en) 2005-03-31 2006-10-05 Microphage Incorporated Apparatus and method for detecting microorganisms using flagged bacteriophage
US20110059514A1 (en) * 2007-01-09 2011-03-10 David Alexander Schofield Yeast Biocatalysts for Degradation of Biowarfare Agents
DK2185699T3 (en) 2007-08-22 2018-01-22 Hyglos Invest Gmbh NEW PROTEINS FOR USE IN STAPHYLOCOCCUS INFECTIONS IN HUMAN AND ANIMALS
KR100974185B1 (ko) * 2007-08-27 2010-08-05 주식회사 인트론바이오테크놀로지 박테리오파지 유래 용균단백질 작용에 의해 제조된세균파쇄물 및 이를 포함하는 동물질병 예방용 백신 조성물
WO2009082525A2 (en) 2007-10-01 2009-07-02 Guild Associates, Inc. Differentially fluorescent yeast biosensors for the detection and biodegradation of chemical agents
US20090104157A1 (en) * 2007-10-05 2009-04-23 E. I. Du Pont De Nemours And Company Utilization of bacteriophage to control bacterial contamination in fermentation processes
CN101220350B (zh) * 2007-11-16 2010-05-19 珠海市晋平科技有限公司 一种分离的李斯特单核增生菌噬菌体及其应用
AU2008328584A1 (en) * 2007-11-26 2009-06-04 Plant Bioscience Limited Novel polypeptides having endolysin activity and uses thereof
US8697434B2 (en) 2008-01-11 2014-04-15 Colorado School Of Mines Detection of phage amplification by SERS nanoparticles
US9441204B2 (en) 2008-04-03 2016-09-13 Colorado School Of Mines Compositions and methods for detecting Yersinia pestis bacteria
EP2143729A1 (de) * 2008-07-07 2010-01-13 Hyglos Invest GmbH Neues enzymatisches Aktivenzym gegen Clostridium
GB0815484D0 (en) 2008-08-26 2008-10-01 Univ Leuven Kath Antibacterial agents
PL215522B1 (pl) 2008-09-29 2013-12-31 Inst Immunologii I Terapii Doswiadczalnej Pan Nowe szczepy bakteriofagów do leczenia zakazen bakteryjnych, zwlaszcza szczepami bakterii lekoopornych rodzaju Enterococcus
GB0908949D0 (en) 2009-05-26 2009-07-01 Plant Bioscience Ltd Novel polypeptides having endolysin activity and uses thereof
DK2445515T3 (en) 2009-06-26 2016-07-04 Univ Leuven Kath antimicrobial agents
KR101701890B1 (ko) 2009-06-26 2017-02-02 뤼산도 아게 항균제
US8778669B2 (en) 2009-07-22 2014-07-15 Corning Incorporated Multilayer tissue culture vessel
SG178440A1 (en) 2009-08-24 2012-04-27 Univ Leuven Kath New endolysin obpgplys
EP2338916A1 (de) 2009-12-23 2011-06-29 Hyglos Invest GmbH Chimäre Polypeptide und ihre Verwendung zur bakteriellen Dekolonisation
EP2397548A1 (de) 2010-06-18 2011-12-21 Hyglos Invest GmbH Verfahren zur Herstellung und zum Screening von lytischen chimärischen Polypeptiden
PL212258B1 (pl) 2010-06-20 2012-09-28 Inst Immunologii I Terapii Doswiadczalnej Pan Nowe szczepy bakteriofagów do leczenia zakazen bakteryjnych, zwlaszcza szczepami bakterii lekoopornych rodzaju Stenotrophomonas
US8962297B2 (en) * 2010-09-01 2015-02-24 The United States Of America, As Represented By The Secretary Of Agriculture Bacteriophage lytic enzymes as alternative antimicrobials
WO2014209912A1 (en) 2013-06-27 2014-12-31 Starbucks Corporation D/B/A Starbucks Coffee Company Biopreservation methods for beverages and other foods
EP3372091A1 (de) * 2017-03-07 2018-09-12 Nomad Bioscience GmbH Verfahren zur verringerung der verschmutzung eines objekts mit clostridium
WO2021009302A1 (en) * 2019-07-18 2021-01-21 Technische Universität München Host-independent expression of bacteriophages
EP4721573A1 (de) * 2024-10-03 2026-04-08 Consejo Superior De Investigaciones Científicas - CSIC Kombination aus bakteriophagen-abgeleiteten endolysinen und glucoseoxidase und verwendungen davon

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3094466A (en) * 1959-07-15 1963-06-18 Warner Lambert Pharmaceutical Preparation for typing of staphylococci and process therefor
US3002892A (en) * 1960-01-20 1961-10-03 Elmo S Dooley Process for preparing bacteriophage-impregnated paper discs for rapid identificationof bacterial strains
US3793151A (en) * 1972-07-10 1974-02-19 J Denney Method of screening for anticapsular substances
US4618576A (en) * 1984-02-27 1986-10-21 Becton Dickinson And Company Diagnostic test for Streptococcus A
IT1197924B (it) * 1986-10-28 1988-12-21 Prodotti Antibiotici Spa Procedimento per la preparazione di alimenti di origine animale
GB8710795D0 (en) * 1987-05-07 1987-06-10 Microbial Dev Ltd Antimicrobial preparations
US4859597A (en) * 1987-07-27 1989-08-22 Igene Biotechnology, Inc. Production of phage and phage-associated lysin
GB8816693D0 (en) * 1988-07-13 1988-08-17 Agricultural & Food Res Viral enzyme & gene

Also Published As

Publication number Publication date
US5763251A (en) 1998-06-09
EP1300082A2 (de) 2003-04-09
AU650737B2 (en) 1994-06-30
GB2255561B (en) 1995-06-21
DE69233152T2 (de) 2004-05-27
EP0510907A2 (de) 1992-10-28
EP0510907B1 (de) 2003-08-13
US6083684A (en) 2000-07-04
EP1300082A3 (de) 2003-11-19
GB9108498D0 (en) 1991-06-05
DE69233152D1 (de) 2003-09-18
GB2255561A (en) 1992-11-11
CA2066387A1 (en) 1992-10-21
CA2066387C (en) 2003-07-01
EP0510907A3 (en) 1993-03-03
AU1502392A (en) 1992-10-22

Similar Documents

Publication Publication Date Title
ATE247169T1 (de) Bacteriophagen-lysine und deren anwendungen zum vernichten von und testen auf bakterien
Spratt et al. Penicillin-binding proteins and cell shape in E. coli
Olson et al. Effects of freezing and storage temperature on MS2 viability
DE69837348D1 (de) Verfahren zur inaktivierung von bakterien mit einbegriff von bakteriensporen
ES8900143A1 (es) Metodo para obtener un vector de transferencia de bacteriofago recombinante
NO953643D0 (no) Nytt middel til kontroll av celleaktivitet
Hoadley et al. Bacterial indicators-health hazards associated with water
Fish et al. The SOS chromotest kit: a rapid method for the detection of genotoxicity
Mazzotti et al. In vitro pyrogen test—A new test method for solid medical devices
Holland et al. Some properties of a new bacteriocin formed by Bacillus megaterium
Frankel et al. Adsorption specificity of bacteriophage PBS1
Yang et al. Construction of an integration-proficient vector based on the site-specific recombination mechanism of Enterococcal temperate phage ΦFC1
Gaidelytė et al. The linear double-stranded DNA of phage Bam35 enters lysogenic host cells, but the late phage functions are suppressed
Mårdh Elimination of mycoplasmas from cell cultures with sodium polyanethol sulphonate
Alexander Leptospirosis in laboratory mice
Douglas et al. Micro-electrophoresis of pox viruses in molar sucrose
Oblinger et al. Inhibitory effects of Pseudomonas on selected Salmonella and bacteria isolated from poultry
Xu et al. Inactivation of Bacillus anthracis spores by a combination of biocides and heating under high-temperature short-time pasteurization conditions
Rocourt et al. Isolement de bactériophages de Listeria seeligeri et L. welshimeri. Lysotypie de L. monocytogenes, L. ivanovii, L. innocua, L. seeligeri et L. welshimeri
Lakicevic et al. Influence of two different culture media on biofilm formation by Listeria monocytogenes isolated from a small-scale meat processing facility
RU2000112381A (ru) Способ экспрессного определения антибиотиков биологическим методом
GALVEZ et al. Full title
Palmer Inadequate response to" adequate" treatment of bacterial infection: L forms and" bactericidal" antibiotic activity
Mercer et al. Interference with multiplication of Pc phage by a factor produced by exposure of Pseudomonas aeruginosa to inactivated Pc phage
Gálvez Martín et al. Standard requirement of a microbiological quality control program for the manufacture of human mesenchymal stem cells for clinical use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0510907

Country of ref document: EP

REN Ceased due to non-payment of the annual fee